Nxera Pharma CoSOLTF 84 Median PS Value is $26.52 as of Jun. 25, 2026, which is 4248% above its 10-year median of 0.61. GuruFocus rates SOLTF with a GF Score™ of 84/100 and a GF Value™ of $7.78 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 277 Biotechnology companies, Nxera Pharma Co ranks better than 84.48% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Nxera Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $2.173. Nxera Pharma Co's 10-Year median PS Ratio is 12.2043. Therefore, the Median PS Value for today is $26.52.
As of today (2026-06-25), Nxera Pharma Co's share price is $6.37. Nxera Pharma Co's Median PS Value is $26.52. Therefore, Nxera Pharma Co's Price to Median PS Value for today is 0.24.
The historical rank and industry rank for Nxera Pharma Co's Median PS Value or its related term are showing as below:
SOLTF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.18 Med: 0.61 Max: 1.39
Current: 0.24
During the past 13 years, the highest Price to Median PS Value of Nxera Pharma Co was 1.39. The lowest was 0.18. And the median was 0.61.
SOLTF's Price-to-Median-PS-Value is ranked better than 84.48% of 277
companies
in the Biotechnology industry
Industry Median: 0.63
vs SOLTF: 0.24
Nxera Pharma Co (OTCPK:SOLTF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Nxera Pharma Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
6.37
/
26.52
=
0.24
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nxera Pharma Co Median PS Value Related Terms
Nxera Pharma Co Median PS Value Historical Data
* Premium members only.
The historical data trend for Nxera Pharma Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SOLTF vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, Nxera Pharma Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nxera Pharma Co Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Nxera Pharma Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 12.2043.
Nxera Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.173.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nxera Pharma Co (SOLTF) has a Median PS Value of $26.52 as of Jun. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Nxera Pharma Co and its competitors. This is 4248% above median its historical median of 0.61. Over the past decade, Nxera Pharma Co's Median PS Value has ranged from 0.18 to 1.39. According to the industry distribution chart, Nxera Pharma Co ranks #43 out of 277 companies in the Biotechnology industry, placing it in the top 15.5%.
Is Nxera Pharma Co's Median PS Value too high?
Nxera Pharma Co's current Median PS Value of $26.52 is 4248% above median its 10-year median of 0.61. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 1.39. The Biotechnology industry median Median PS Value is 0.63. Nxera Pharma Co's value of $26.52 is 4109.5% above this industry median. Based on the distribution chart, Nxera Pharma Co ranks #43 out of 277 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Nxera Pharma Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nxera Pharma Co's Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nxera Pharma Co ranks #43 out of 277 companies for Median PS Value. This places Nxera Pharma Co in the top 16% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.63. Nxera Pharma Co's value of $26.52 is 4109.5% above this benchmark. Historically, Nxera Pharma Co's own Median PS Value has ranged from 0.18 to 1.39 over the past decade. While the company's 10-year median is 0.61 vs. the industry median of 0.63, Nxera Pharma Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.63, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nxera Pharma Co's current Median PS Value of $26.52 is 4109.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Nxera Pharma Co and its competitors. For the Biotechnology industry, the median Median PS Value is 0.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nxera Pharma Co's current Median PS Value is $26.52, which is 4248% above median its own 10-year median of 0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nxera Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Nxera Pharma Co (SOLTF) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.78, compared to a current price of $6.37 — trading 18.1% below its estimated fair value. The current Median PS Value is $26.52, which is 4248% above median its 10-year median of 0.61 and 4109.5% above the Biotechnology industry median of 0.63. Nxera Pharma Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Nxera Pharma Co (SOLTF), the current Median PS Value is $26.52 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nxera Pharma Co (SOLTF) Overvalued in 2026?
Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be undervalued.
The current stock price of $6.37 is trading 18.1% below its estimated GF Value™ of $7.78.
GuruFocus considers Nxera Pharma Co to be Modestly Undervalued.
Key valuation signals for SOLTF:
Median PS Value: $26.52 (4248% above median its 10-year median of 0.61)
GF Value™: $7.78 vs. price of $6.37 (18.1% below fair value)
Industry Position: 4109.5% above the Biotechnology median (#43 of 277)
No single metric tells the full story. See the SOLTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
84GF Score
Get the complete analysis for SOLTF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SOLTF has been successfully added to your 
